Molecular characterization of the chromosome 9q deletion in AML.

Molecular characterization of the chromosome 9q deletion in AML.

Bibliographic Details
Main Authors:	Side, L, Peniket, A, Levy, E, Williamson, H, Humphray, S, Langabeer, SE, Walker, H, Goldstone, A, Linch, D, Burnett, A, Boultwood, J, Wainscoat, J
Format:	Journal article
Published:	2000

Similar Items

Physical and transcriptional characterization of the commonly deleted region in del(9q) AML.
by: Daly, S, et al.
Published: (2001)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
by: Peniket, A, et al.
Published: (1999)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
by: Peniket, A, et al.
Published: (2005)

Identification of candidate tumor suppressor genes in the commonly deleted region of del(9q) AML.
by: Sweetser, D, et al.
Published: (2002)

Genes located within the del(9q) commonly deleted region are down-regualted in acute myeloid leukaemia.
by: Zhao, Z, et al.
Published: (2004)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
by: Kottaridis, P, et al.
Published: (2000)

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
by: Kottaridis, P, et al.
Published: (2001)

Subtelomeric deletions of chromosome 9q: a novel microdeletion syndrome.
by: Stewart, DR, et al.
Published: (2004)

Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
by: Lewis, S, et al.
Published: (1995)

Chromosomal deletions in myelodysplasia.
by: Boultwood, J, et al.
Published: (1995)

Molecular characterization of the 7q deletion in myeloid disorders.
by: Lewis, S, et al.
Published: (1996)

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS
by: Lewis, S, et al.
Published: (1993)

Practical considerations in the analysis of chromosomal deletion breakpoints by pulsed field gel electrophoresis.
by: Abrahamson, G, et al.
Published: (1991)

Narrowing the critical deleted region in the 5q-syndrome.
by: Jaju, R, et al.
Published: (1996)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
by: Grimwade, D, et al.
Published: (1999)

Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
by: Sweetser, D, et al.
Published: (2005)

MOLECULAR DELINEATION OF THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
by: Boultwood, J, et al.
Published: (1993)

Homozygous deletion of FMS in a patient with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (1990)

Lineage studies of 5q deletions using combined immunophenotyping and fish.
by: Jaju, R, et al.
Published: (1999)

MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
by: Boultwood, J, et al.
Published: (1993)

Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.
by: Boultwood, J, et al.
Published: (1994)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
by: Grimwade, D, et al.
Published: (1996)

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2002)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
by: Grimwade, D, et al.
Published: (2001)

Association between reproducible flow cytometric methodology for measuring multidrug resistance and remission rates in AML
by: Pallis, M, et al.
Published: (1998)

Molecular diagnosis of the 5q deletion in malignant myeloid disorders.
by: Boultwood, J
Published: (1996)

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood AML.
by: Jaju, R, et al.
Published: (1998)

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials
by: Hills, R, et al.
Published: (2018)

ISOLATION OF NOVEL CDNA CLONES MAPPING TO THE CRITICAL REGION OF THE 5Q-CHROMOSOME IN THE 5Q-SYNDROME
by: Boultwood, J, et al.
Published: (1994)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome.
by: Jaju, R, et al.
Published: (1998)

Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
by: Boultwood, J, et al.
Published: (1991)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

A novel gene is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood AML.
by: Jaju, R, et al.
Published: (2000)

Chorea-acanthocytosis: genetic linkage to chromosome 9q21.
by: Rubio, J, et al.
Published: (1997)

Constitutional deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy.
by: Aldred, M, et al.
Published: (2002)

5q- syndrome.
by: Boultwood, J, et al.
Published: (2012)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
by: Wheatley, K, et al.
Published: (1995)

Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.
by: Jadersten, M, et al.
Published: (2005)

Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (1993)